Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Melissa
    Senior Member
    • Aug 2008
    • 124

    Samtools pileup SNPs questions

    Hi, I'm using pileup to look for SNPs from bowtie alignment. There are several questions I wanna ask. Your help is greatly appreciated.

    1. I observed the maximum SNP quality is 228. Is it correct?

    2. $7 is always 60. What's wrong?

    3. What does the symbol "$" or "^F" means in $8?

    4. Will considering a SNPs site that are covered by reads from plus & minus strand reduce false positive?

    5. Also, I noticed BWA maps less reads compared to Bowtie. It gives a lower mapping score, lower SNP quality score and thus, less SNPs. Can I trust these SNPs that are found in bowtie but not BWA alignment?

    Cheers,
    Melissa
  • lh3
    Senior Member
    • Feb 2008
    • 686

    #2
    1. it depends on your data

    2. in repetitive regions, you will see smaller numbers

    3. see FAQ

    4. see maq paper. it considers this effect, but probably not as much as it should

    5. bowtie does not have a mapping score. in my evaluation, bwa always gives better alignment and better snp calls, but you know my answer is likely to be biased.

    Comment

    • sowmyai
      Member
      • Jan 2010
      • 27

      #3
      I too noticed that all most of my SNPs had quality score of 228. But I had a couple of 255s. Did you ever find out what's magical about 228 ?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 12:17 PM
      0 responses
      13 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      14 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      37 views
      0 reactions
      Last Post SEQadmin2  
      Working...